Varenicline + Nicotine patch
ApprovedWithdrawn 0 views this week 0 watching💤 Quiet
Interest: 25/100
25
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Tobacco Use Cessation
Conditions
Tobacco Use Cessation, Psychiatric Disorders
Trial Timeline
Jan 1, 2019 → Apr 1, 2020
NCT ID
NCT03809897About Varenicline + Nicotine patch
Varenicline + Nicotine patch is a approved stage product being developed by Rafael Holdings for Tobacco Use Cessation. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT03809897. Target conditions include Tobacco Use Cessation, Psychiatric Disorders.
What happened to similar drugs?
6 of 9 similar drugs in Tobacco Use Cessation were approved
Approved (6) Terminated (2) Active (2)
Hype Score Breakdown
Clinical
20
Activity
0
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03809897 | Approved | Withdrawn |
Competing Products
20 competing products in Tobacco Use Cessation